1Border WA, Noble NA, Ketteler M. TGF -β: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int, 1995,47 (Suppl 49 ) : 59 - 61.
2Chou WC, Prokova V, Shiraishi K, et al. Mechanism of a transcriptional cross talk between transforming growth factor-beta- regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor 4. Mol Bidl Cell,2003,14(3) : 1279-1294.
3Inoki K, Haneda M, Ishida T, et al. Role of mitogen-activated protein kinases downstream effectors of transforming growth factor - beta in mesangial cells. Kidney Int,2000,58(Suppl 77) :76 - 80.
4Floege J, Eng E, Young BA,et al. Infusion of platelet-derived growth factor or basic fibroblast growth factor inducess elective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest, 1993,92 (6):2952 -2962.
5Johnson RJ, Floege J, Couser WG, et al. Role of platelet -derived growth factor in glomerular disease. J Am Soc Nephrol, 1993,4(2): 119 - 128.
7Johnson RJ,Raines EW,Floege J,et al.Inhibition of mesangial cell proliferation and matrix expansion in glomeru lonephritis in the rat by antibody to platelet-derived growth factor.J Exp Med,1992,175(5):1413—1416.
8Ito Y,Aten J,Bende RJ,et al.Expression of connective tissue growth factor in human renal fibrosis.Kidney Int,1998,584(4):853—861.
9Frazier K,Williams S,Kothalpalli D,et al.Stimulation of fibroblast cell growth,matrix production,and granulation tissue formation by connective tissue growth factor.J Invest Dermatol,1996,107(3):404—411.
10Murphy M, Godson C, Cannon S, et al. Suppression subtractive hybridization identifies high glucose levels as astimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Bio Chem,1999,274(9) :5830 - 5834.
